Point72 Asset Management’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-14,327
Closed -$827K 2242
2024
Q2
$827K Buy
+14,327
New +$702K ﹤0.01% 1319
2023
Q4
Sell
-2,087
Closed -$341K 2631
2023
Q3
$341K Buy
2,087
+2,086
+208,600% +$492K ﹤0.01% 1622
2023
Q2
$387 Sell
1
-307
-100% -$93.6K ﹤0.01% 2029
2023
Q1
$85.1K Buy
+308
New +$113K ﹤0.01% 1664
2021
Q4
Sell
-3,566
Closed -$2.65M 1234
2021
Q3
$2.65M Sell
3,566
-3,994
-53% -$2.72M 0.01% 757
2021
Q2
$5.67M Buy
+7,560
New +$5.78M 0.03% 584

Other funds holding OM

Point72 Asset Management's OM Position: Q3 2024 in Review

Point72 Asset Management sold out of Outset Medical (OM) in Q3 2024, closing a stake of 14,327 shares — an estimated $827K sold.

Point72 Asset Management first reported a position in OM in Q2 2021 and held it in 6 quarters. The position peaked at $5.67M in Q2 2021. 78 funds tracked by Wall St. Rank hold OM as of Q3 2024.

  • Point72 Asset Management reported no remaining Outset Medical position as of Q3 2024 after selling out during the quarter.
  • Point72 Asset Management sold 14,327 Outset Medical shares in Q3 2024, an estimated $827K.
  • Point72 Asset Management first reported a position in Outset Medical in Q2 2021 and held it in 6 quarters.
  • Point72 Asset Management's Outset Medical position peaked at $5.67M in Q2 2021.
  • 78 funds tracked by Wall St. Rank held Outset Medical as of Q3 2024.

Based on Point72 Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.